ReviewCancer journal (Sudbury, Mass.)

Cost-effectiveness of New Targeted Agents in the Treatment of Chronic Lymphocytic Leukemia.

R Andrew Harkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.